Hot Features
プレミアム
Exelixis Inc (EXEL)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Mr. Patrick Joseph HaleyExec. VP of Commercial | -32.11k | 1.60M | 売り | 49.81 | 357.64k | -8.24% |
| 2026-05-15 | Mr. Christopher J. SennerExec. VP & CFO | -40.89k | 2.09M | Sale to Issuer | 51.10 | 551.13k | -6.91% |
| 2026-05-18 | Dr. Brenda J. HeftiSenior VP & General Counsel | -6.63k | 332.64k | Automatic Disposition | 50.21 | 6.25k | -51.46% |
| 2026-05-18 | Mr. Christopher J. SennerExec. VP & CFO | -34.90k | 1.75M | 売り | 50.00 | 551.13k | -5.96% |
| 2026-05-15 | Dr. Brenda J. HeftiSenior VP & General Counsel | -6.41k | 327.60k | Sale to Issuer | 51.10 | 6.25k | -50.64% |
| 2026-05-18 | Dr. Michael M. MorrisseyCEO, President & Director | -124.05k | 0.00 | Other Disposition | - | 3.38M | -3.54% |
| 2026-05-15 | Dr. Michael M. MorrisseyCEO, President & Director | -128.50k | 6.57M | Sale to Issuer | 51.10 | 3.38M | -3.66% |
| 2026-05-15 | Mr. Patrick Joseph HaleyExec. VP of Commercial | -33.27k | 1.70M | Sale to Issuer | 51.10 | 389.75k | -7.86% |
| 2026-05-15 | Dr. Dana T. AftabExec. VP of Research & Development | -30.58k | 1.56M | Sale to Issuer | 51.10 | 238.06k | -11.38% |
| 2026-05-07 | Dr. Maria C. FreireIndependent Director | -20.63k | 541.23k | Derivative Exercise and Sale | 19.77 - 46.00 | 91.01k | - |
| 2026-05-07 | Dr. Mary C. BeckerleIndependent Director | -3.86k | 186.82k | 売り | 48.45 | 17.52k | -18.04% |
| 2026-05-07 | Dr. Mary C. BeckerleIndependent Director | -3.86k | 97.21k | Derivative Exercise and Sale | 23.24 - 48.45 | 17.52k | - |
| 2026-02-24 | Dr. Michael M. MorrisseyCEO, President & Director | -100.28k | 0.00 | Other Disposition | - | 2.01M | -4.76% |
| 2026-02-24 | Dr. Dana T. AftabExec. VP of Research & Development | -47.92k | 2.13M | 売り | 44.50 | 207.90k | -18.73% |
| 2026-02-19 | Dr. Dana T. AftabExec. VP of Research & Development | -29.87k | 1.32M | 売り | 44.35 | 255.82k | -10.46% |
| 2026-02-18 | Mr. Jack L. WyszomierskiIndependent Director | -20.63k | 500.17k | Derivative Exercise and Sale | 19.77 - 44.01 | 270.13k | - |
| 2026-02-18 | Mr. Jack L. WyszomierskiIndependent Director | -78.94k | 3.47M | Automatic Disposition | 44.01 | 270.13k | -22.61% |
| 2026-02-17 | Ms. Julie Anne SmithIndependent Director | -106.54k | 2.63M | Derivative Exercise and Sale | 18.19 - 44.50 | 10.78k | - |
| 2026-02-13 | Dr. Sue Gail EckhardtIndependent Director | -3.86k | 168.85k | Automatic Disposition | 43.79 | 0.00 | -100.00% |
| 2026-02-18 | Dr. Brenda J. HeftiSenior VP & General Counsel | -18.67k | 821.62k | Automatic Disposition | 44.01 | 6.08k | -75.42% |
| 2026-02-15 | Dr. Brenda J. HeftiSenior VP & General Counsel | -5.43k | 238.49k | Sale to Issuer | 43.92 | 6.08k | -47.16% |
| 2026-02-15 | Dr. Dana T. AftabExec. VP of Research & Development | -39.21k | 1.72M | Sale to Issuer | 43.92 | 285.69k | -12.07% |
| 2026-02-13 | Mr. Robert Lee OliverIndependent Director | -9.09k | 221.11k | Derivative Exercise and Sale | 19.28 - 43.61 | 2.22k | - |
| 2026-02-13 | Mr. Robert Lee OliverIndependent Director | -21.16k | 929.01k | 売り | 43.90 | 2.22k | -90.51% |
| 2026-02-13 | Dr. Michael M. MorrisseyCEO, President & Director | -494.70k | 10.98M | Derivative Exercise and Sale | 21.31 - 43.92 | 2.11M | - |
| 2026-02-17 | Dr. Michael M. MorrisseyCEO, President & Director | -371.13k | 0.00 | Other Disposition | - | 2.11M | -14.97% |
| 2026-02-13 | Mr. Christopher J. SennerExec. VP & CFO | -64.90k | 2.81M | 売り | 43.00 - 43.67 | 551.13k | -10.53% |
| 2026-02-15 | Mr. Christopher J. SennerExec. VP & CFO | -35.87k | 1.58M | Sale to Issuer | 43.92 | 551.13k | -6.11% |
| 2026-02-17 | Mr. Patrick Joseph HaleyExec. VP of Commercial | -67.81k | 2.95M | 売り | 43.50 - 43.84 | 0.00 | -100.00% |
| 2026-02-15 | Mr. Patrick Joseph HaleyExec. VP of Commercial | -31.48k | 1.38M | Sale to Issuer | 43.92 | 0.00 | -100.00% |
| 2026-01-15 | Mr. Christopher J. SennerExec. VP & CFO | -40.46k | 1.83M | Sale to Issuer | 45.23 | 585.40k | -6.46% |
| 2026-01-15 | Mr. Patrick Joseph HaleyExec. VP of Commercial | -32.33k | 1.46M | Sale to Issuer | 45.23 | 37.42k | -46.35% |
| 2026-01-15 | Dr. Dana T. AftabExec. VP of Research & Development | -27.25k | 1.23M | Sale to Issuer | 45.23 | 247.84k | -9.91% |
| 2026-01-15 | Dr. Michael M. MorrisseyCEO, President & Director | -139.52k | 6.31M | Sale to Issuer | 45.23 | 1.87M | -6.95% |
| 2025-11-10 | Farallon Capital Management, L.L.C.法人 | 96.37k | 3.95M | 買い | 40.32 - 40.96 | 15.71M | 0.62% |
| 2025-11-13 | Farallon Capital Management, L.L.C.法人 | -4.17M | 0.00 | 売り | 40.77 - 44.50 | 15.71M | -20.97% |
| 2025-11-25 | Caligan Partners, LP法人 | 27.53k | 1.19M | 買い | 43.12 | 1.55M | 1.80% |
| 2025-11-20 | Mr. Patrick Joseph HaleyExec. VP of Commercial | -72.23k | 3.05M | 売り | 41.77 - 42.58 | 0.00 | -100.00% |
| 2025-11-21 | Dr. Dana T. AftabExec. VP of Research & Development | -24.00k | 0.00 | Other Disposition | - | 215.31k | -10.03% |
| 2025-11-17 | Mr. Robert Lee OliverIndependent Director | -1.04k | 0.00 | Other Disposition | - | 23.38k | -4.27% |
| 2025-11-11 | Dr. Mary C. BeckerleIndependent Director | -5.78k | 108.68k | Derivative Exercise and Sale | 23.24 - 42.03 | 0.00 | - |
| 2025-11-11 | Dr. Mary C. BeckerleIndependent Director | -18.84k | 789.31k | 売り | 41.90 | 0.00 | -100.00% |
| 2025-11-11 | Dr. Michael M. MorrisseyCEO, President & Director | -341.55k | 0.00 | Other Disposition | - | 1.73M | -16.47% |
| 2025-11-11 | Dr. Dana T. AftabExec. VP of Research & Development | -48.38k | 2.06M | 売り | 42.50 | 239.31k | -16.82% |
| 2025-11-12 | Dr. Stelios PapadopoulosCo-Founder & Independent Chair of the Board | -100.00k | 4.36M | 売り | 43.55 | 1.18M | -7.82% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
